These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2685445)

  • 1. [Comparative effectiveness of intracoronary and systemic thrombolytic therapy of acute myocardial infarction].
    Khalfen ESh; Shtern SV; Shvarts IL; Bezrukova GA; Zolotarev VA; Rakovskiĭ ME
    Kardiologiia; 1989 Aug; 29(8):15-9. PubMed ID: 2685445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intracoronary thrombolytic therapy of myocardial infarction].
    Khalfen ESh; Shtern SV
    Ter Arkh; 1985; 57(5):79-84. PubMed ID: 3927500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolytic therapy of acute myocardial infarction.
    Little WC
    Curr Probl Cardiol; 1983 Dec; 8(9):1-47. PubMed ID: 6661925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of intracoronary and intravenous methods of thrombolytic streptokinase therapy of patients with myocardial infarct].
    Markov VA; Varvarenko VI; Kun VI; Krylov AL; Stoliarov VA
    Kardiologiia; 1988 May; 28(5):20-3. PubMed ID: 3411854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic versus intracoronary thrombolytic treatment in acute myocardial infarction.
    Verstraete M
    Acta Cardiol; 1985; 40(3):263-7. PubMed ID: 3895791
    [No Abstract]   [Full Text] [Related]  

  • 6. [Status of the coronary arteries after thrombolytic therapy of myocardial infarction].
    Savchenko AP
    Klin Med (Mosk); 1991 Jan; 69(1):13-6. PubMed ID: 2023387
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yaşar AS; Bilen E; Yüksel IO; Arslantaş U; Karakaş F; Kirbaş O; Bilge M
    Turk Kardiyol Dern Ars; 2010 Mar; 38(2):85-9. PubMed ID: 20473008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous versus intracoronary streptokinase for acute transmural myocardial infarction.
    Blunda M; Meister SG; Shechter JA; Pickering NJ; Wolf NM
    Cathet Cardiovasc Diagn; 1984; 10(4):319-27. PubMed ID: 6488304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of patency as an end point of thrombolytic therapy.
    Anderson JL
    Am J Cardiol; 1991 Dec; 68(16):11E-16E. PubMed ID: 1746446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective thrombolytic patency of the coronary arteries in patients with acute myocardial infarction].
    Ekha IaE; Rebane TKh; Lukha OA; Leĭssoo AR; Serka TT
    Kardiologiia; 1983 Sep; 23(9):9-12. PubMed ID: 6417392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the effect of intravenous administration of streptokinase in acute myocardial infarction].
    Poloński L; Tendera M; Adamowicz E; Wodniecki J; Szczurek K; Wedrychowicz A
    Pol Arch Med Wewn; 1987; 77(1-2):16-24. PubMed ID: 3275388
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation between D-dimer levels and coronary artery reperfusion in acute myocardial infarction patients after thrombolytic treatment.
    Cakar MA; Gunduz H; Varim C; Ozdemir F; Vatan MB; Akdemir R
    Blood Coagul Fibrinolysis; 2013 Sep; 24(6):608-12. PubMed ID: 23917585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of thrombolytic therapy with intravenous streptokinase on the size of myocardial infarction estimated by the ECG QRS score system].
    Machavariani PT; Agladze VT; Iosava LI; Tsirekidze OU; Iosava KV
    Kardiologiia; 1992 May; 32(5):67-70. PubMed ID: 1405268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose streptokinase therapy with three million units in one hour significantly improves early coronary patency rates in acute myocardial infarction.
    Theiss W; Busch U; Renner U; Blömer H
    Am J Cardiol; 1996 Nov; 78(10):1167-9. PubMed ID: 8914885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of anistreplase on coronary patency in acute myocardial infarction].
    Pacouret G; Charbonnier B
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():25-9. PubMed ID: 2108643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous versus intracoronary streptokinase in acute myocardial infarction.
    Lo YS
    Clin Cardiol; 1985 Dec; 8(12):609-19. PubMed ID: 4075606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is survival in acute myocardial infarction related to thrombolytic efficacy or the open-artery hypothesis? A controversy to be investigated with GUSTO.
    Bates ER
    Chest; 1992 Apr; 101(4 Suppl):140S-150S. PubMed ID: 1555479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arterial permeability, objective of thrombolytic therapy].
    Bassand JP; Schiele F; Bernard Y; Anguenot T
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):677-87. PubMed ID: 1530409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombolytic therapy in acute myocardial infarct].
    Verstraete M
    Recenti Prog Med; 1990 Apr; 81(4):287-98. PubMed ID: 2198644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic therapy. A new strategy for the treatment of acute myocardial infarction (2).
    Laffel GL; Braunwald E
    N Engl J Med; 1984 Sep; 311(12):770-6. PubMed ID: 6236369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.